1. The anthracyclines;Weiss;Semin Oncol,1992
2. Arcamone F, Doxorubicin. Anticancer Antibiotics, Medicinal Chemical Series, Vol. 17. Academic Press, New York, 1981.
3. DNA topoisomerase II as the primary target of anti-tumor anthracyclines;Zunino;Anticancer Drug Des,1992
4. Sequence-selective groove binders;Zunino,1997
5. Influence of structural modifications at the 3′ and 4′ positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance;Capranico;Mol Pharmacol,1994